Pathlabs 

www.wellspring.in

The pathlabs market in India is estimated at Rs 3,000 crores, growing at a CAGR of 20 per cent annually. This market is highly fragmented with very few large players. There is a perceived opportunity for accredited high quality testing as the overall standards for health care in the country increase. NPIL's strategy is to exploit this opportunity through a three-pronged approach.

This business will grow through the acquisition of established, reputed labs in metros, which will create the foundation on which the business will be built. These labs will be expanded rapidly by increasing the range of offerings and enhancing the geographical coverage through branches and collection centers. Accreditation from the National Accrediation Board for Testing and Calibration of Laboratories, Government of India, (NABL) will be obtained for each of these labs and an umbrella brand be established to leverage this opportunity.

NPIL's path labs include Drs. Tribedi & Roy Diagnostic Laboratories Pvt. Limited in Kolkata, the NPIL - Dr. Phadke Pathology Laboraory & Infertility Center Pvt. Limited, in Mumbai, have accreditation from the National Accrediation Board for Testing and Calibration of Laboratories (NABL), Government of India. 

NPIL's labs offer a wide range of Pathogolgy investigation test which include Immunology tests, Haemotology, Micro-biology, Infertility investigations and Histopathology examinations, among others. All of NPIL's labs use state-of-the-art equipment of the highest quality and have highly qualified teams of pathologists and technicians.